Pharmacokinetics study of Pazufloxacin Mesilate in multiple doses to chinese healthy volunteers
Zheng Zhuan-jie
Abstract
Zheng Zhuan-jie
Abstract
Objective:To investigate the pharmacokinetics of pazufloxacin mesilate in multiple doses to Chinese healthy volunteers.Methods:The protocol was designed according to GCP principle.10 volunteers were given multi-dose pazufloxacin mesilate and the plasma concentrations were determined by HPLC method and the pharmacokinetics parameters were calculated by DAS1.0 software.Results:The concentration-time curve fit two compartment model.The main pharmacokinetics parameters C0 of the 1st day and 5th day were (5.73±0.79)mg/L and (5.72±0.82)mg/L respectively,t1/2β were (2.01±0.27)h and (1.85±0.20)h respectively,AUC0-∞ of the 1st day was (13.50±2.47)mg·h·L-1 and AUC0-τ of the 5th day was (14.53±2.71) mg·h·L-1.Conclusion:Effective concentration in vivo could achieved after intravenous infusion of 300mg pazufloxacin mesilate twice a day for 5 days and no accumulation in human body was observed after 5 day administrations.The dosing schedule was recommended.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the pharmacokinetics of pazufloxacin mesilate in multiple doses to Chinese healthy volunteers.Methods:The protocol was designed according to GCP principle.10 volunteers were given multi-dose pazufloxacin mesilate and the plasma concentrations were determined by HPLC method and the pharmacokinetics parameters were calculated by DAS1.0 software.Results:The concentration-time curve fit two compartment model.The main pharmacokinetics parameters C0 of the 1st day and 5th day were (5.73±0.79)mg/L and (5.72±0.82)mg/L respectively,t1/2β were (2.01±0.27)h and (1.85±0.20)h respectively,AUC0-∞ of the 1st day was (13.50±2.47)mg·h·L-1 and AUC0-τ of the 5th day was (14.53±2.71) mg·h·L-1.Conclusion:Effective concentration in vivo could achieved after intravenous infusion of 300mg pazufloxacin mesilate twice a day for 5 days and no accumulation in human body was observed after 5 day administrations.The dosing schedule was recommended.
Key concepts: Pharmacokinetics, Medicine, Dosing, Pharmacology, Plasma concentration, Serum concentration, Internal medicine